Ireland· IE-PA-EU/1/24/1875/001
Wainzua 45 mg solution for injection in pre-filled pen
A eplontersen product containing eplontersen sodium, registered in Ireland by AstraZeneca AB. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Eplontersen is registered in 13 of 19 countries.
Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Eplontersen · ATC N07XX21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Eplontersen sodium
- Manufacturer
- AstraZeneca AB
- Country
- Ireland (IE)
- ATC code
- N07XX21
- ATC class
- Eplontersen
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/24/1875/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eplontersen in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumWainzua 45 mgAstraZeneca
- CzechiaWAINZUAAstraZeneca AB, Södertälje
- IcelandWainzuaAstraZeneca AB*
- NorwayWainzuaAstraZeneca AB
- SwedenWainzua 45 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Wainzua
- Liechtenstein · Wainzua
- Norway · Wainzua
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/88b6708d-80e0-4498-a9c4-3da4f2a78cd9 GET /v1/drugs/88b6708d-80e0-4498-a9c4-3da4f2a78cd9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"N07XX21"
],
"strength": null,
"pa_number": "EU/1/24/1875/001",
"substances": [
"Eplontersen sodium"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "06/03/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about eplontersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.